Curated data from public databases (IARC TP53, COSMICs, ICGC, and cBioportal) reveal the presence of Arg158 mutp53 in multiple carcinomas; and the effectiveness of mutp53 acetylators in the PDX models of gastric and liver cancers further extends the applicability of these findings to other cancer types. Here, TP53 is linked to cancer.